ACE2 and infection: The angiotensin 2 converting enzyme (ACE2) has been identified as the candidate receptor for SARS-CoV-2 (3, 11), and an upregulation of ACE2 could improve SARS-CoV-2’s ability to infect target cells, such as the alveolar cells, increasing the risk of infection and related respiratory problems (8, 11).